The Synaptic Clock: SynGAP1 as a Molecular Timer of Postsynaptic Density Consolidation

SYNGAP1-related intellectual disability presents a therapeutic paradox where genetic rescue is highly effective in neonates but limited in adults, suggesting that deficiency represents a developmental trajectory violation rather than a static biochemical defect. By synthesizing molecular, biophysical, and clinical evidence, this review proposes the "Synaptic Clock" framework, redefining SynGAP1 as a critical developmental regulator. We hypothesize that SynGAP1 operates through a strictly ordered temporal sequence: Phase I (Scaffold Assembly) utilizes the α1 isoform and phase separation to establish the structural postsynaptic density, while Phase II (Catalytic Refinement) involves isoform switching to enable activity-dependent plasticity and homeostatic scaling. This model characterizes synaptic maturation as a biophysical transition from a fluid scaffold to a consolidated gel, potentially marking the biological closure of structural rescue windows. Based on this hypothesized temporal mapping, we establish a phase-stratified therapeutic roadmap-transitioning from early-stage "reset" strategies like gene replacement to late-stage "refinement" and "compensation" via pharmacological and neuromodulatory interventions. Ultimately, validating phase-specific biomarkers, including gamma oscillations and isoform stoichiometry, is essential for shifting from generic interventions toward precision, phase-matched medicine for neurodevelopmental timing.